Tocilizumab
Showing 1 - 10 of 10
Tocilizumab, Thyroid Associated Ophthalmopathy Trial in Guangzhou (Tocilizumab)
Recruiting
- Tocilizumab
- Thyroid Associated Ophthalmopathy
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Oct 11, 2023
Ultra-short Glucocorticosteroids and Tocilizumab Therapy in GCA
Active, not recruiting
- GCA
- +3 more
- Tocilizumab 162Mg/0.9Ml Autoinjector
-
Reggio Emilia, Emilia Romagna, ItalyAusl-Irccs - S.C. Di Reumatologia
May 26, 2022
Tocilizumab in Covid-19 Penumonia in Buenos Aires City
Completed
- COVID-19 Pneumonia
- Tocilizumab
-
Buenos Aires, ArgentinaNazareno Galvalisi
May 16, 2022
COVID-19 Virus Infection, Cytokine Storm, Corticosteroid Trial (Methylprednisolone, Tocilizumab)
Withdrawn
- COVID-19 Virus Infection
- +3 more
- (no location specified)
Nov 22, 2021
Takayasu Arteritis, Tocilizumab, Adalimumab Trial in Shanghai (Tocilizumab, Adalimumab)
Recruiting
- Takayasu Arteritis
- +3 more
- Tocilizumab
- Adalimumab
-
Shanghai, Shanghai, ChinaDepartment of Rheumatology in Zhongshan hospital, Fudan Universi
Aug 7, 2021
Tocilizumab in Patients With Severe COVID-19
Recruiting
- Severe COVID 19 Pneumonia
- Tocilizumab
-
Ciudad autónoma de Buenos Aires, Caba, ArgentinaHospital Italiano de Buenos AIres
Jun 10, 2021
Tocilizumab, COVID-19, Critical Care Trial in Trabzon (Tocilizumab)
Completed
- Tocilizumab
- +3 more
-
Trabzon, TurkeyKaradeniz Technical University
May 18, 2021
Cytokine Release Syndrome (CRS) in COVID-19
Unknown status
- Covid-19
- +4 more
- Tocilizumab
- +2 more
-
Wuhan, Hubei, ChinaTongji Hospital
Mar 16, 2020
Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in
Completed
- Arthritis, Rheumatoid
- +2 more
-
Bordeaux, Aquitaine, FranceRheumatology department - Bordeaux University Hospital
Jan 8, 2019
Rheumatoid Arthritis, Tocilizumab Trial in Tel Aviv (Tocilizumab)
Unknown status
- Rheumatoid Arthritis
- Tocilizumab
-
Tel Aviv, IsraelDepartment of Rheumatology, Tel Aviv Medical Center
Dec 23, 2018